Simvastatin Dosage
Links shared publicly online about this topic
FDA puts limit on simvastatin dosage - McKnight's Long Term Care News
mcknights.com — “Physicians should curb prescriptions for the 80-milligram dose of the cholesterol-lowering statin drug simvastatin due to risk of muscle injury, the Food and Drug Administration said Thursday.” View full resource at mcknights.com
Most Recently Shared on June 10, 2011 at 3:22 pm By:
McKnight's LTC News Health News and Medical Publisher
FDA puts limit on simvastatin dosage http://bit.ly/kaUF9g #healthcare
Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths
drugs.com — “Simcor (niacin ER and simvastatin) is used for Hyperlipidemia. Information from Drugs.com includes Simcor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 1:29 am By:
Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths - http://bit.ly/aBBY2A
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin Extended-release/simvastatin)
medicalnewstoday.com — “Abbott has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. simcor is a fi” View full resource at medicalnewstoday.com
Most Recently Shared on December 12, 2009 at 12:22 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin: http://bit.ly/8fMHnz Full http://bit.ly/78Vmva
Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)
medicalnewstoday.com — “Abbott (nyse: abt) has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. s” View full resource at medicalnewstoday.com
Most Recently Shared on December 11, 2009 at 3:19 pm By:
MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin: http://bit.ly/4HlCmF Full http://bit.ly/7vMN53
Abbott's SIMCOR (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths - QualityPoint Technologies
qualitypointtech.net — “Abbott has received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCOR, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin - the most commonly prescribed dose of simvastatin - with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott's proprietary niacin extended-release and simvastatin, the most commonly used statin. SIMCOR is a prescription medication used along with diet i” View full resource at qualitypointtech.net
Most Recently Shared on August 6, 2010 at 2:36 pm By:
Abbott's SIMCOR® (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths: Abbott ... http://bit.ly/av13zh
Additional dosage strengths of Simcor approved - ONA
oncologynurseadvisor.com — “Abbott announced that it has received FDA approval for two new dosage strengths of Simcor (niacin extended-release/simvastatin tablets).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 29, 2010 at 3:22 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Additional dosage strengths of Simcor approved http://goo.gl/fb/uixm5
Additional dosage strengths of Simcor approved - MPR
empr.com — “Abbott announced that it has received FDA approval for two new dosage strengths of Simcor (niacin extended-release/simvastatin tablets).” View full resource at empr.com
Most Recently Shared on July 29, 2010 at 4:02 pm By:
MPR News: Additional dosage strengths of Simcor approved: Abbott announced that it has received FDA approval for t... http://bit.ly/bSA16u
Efficacy of Abbott cholesterol drug in question
news-medical.net — “A latest study has found that using medication to raise good cholesterol while lowering the bad does NOT translate into fewer adverse cardiovascular events like heart attacks and strokes. The study was revealed Thursday by the National Institutes of Health and it found that high dosages of Abbott Laboratories' Niaspan failed to prevent heart attacks and boosted the likelihood of a stroke when combined with the popular generic cholesterol pill Simvastatin, also known under the brand name Zoco” View full resource at news-medical.net
Most Recently Shared on May 29, 2011 at 11:30 pm By:
Stroke News: Efficacy of Abbott cholesterol drug in question: A latest study has found that using medication t... http://twurl.nl/gcfxn5
FDA OKs diabetes, cholesterol combo drug - Related Stories - DiabetesPro SmartBrief
smartbrief.com — “Merck & Co. secured marketing approval from the FDA for Juvisync, a treatment containing the firm's type 2 diabetes pill Januvia and cholesterol-lowering statin simvastatin. The combination was approved for marketing in multiple strengths. "Dose selection should factor in what other drugs the patie…” View full resource at smartbrief.com
Most Recently Shared on October 10, 2011 at 4:03 pm By:
Jill Weisenberger Nutritionist and Dietitian
Available in 6 dosages RT @Eatingsoulfully: FDA OKs diabetes, cholesterol combo drug http://t.co/5Wp37M2a #diabetes
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
McKnight's LTC News
A resource for all things long-term care, monitored by editor Elizabeth Newman.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
Advertisement
